| Literature DB >> 24250381 |
Ramin Miri1, Katayoun Javidnia, Zahra Amirghofran, Seyyed Hossein Salimi, Zahra Sabetghadam, Savis Meili, Ahmad Reza Mehdipour.
Abstract
The 1,4-dihydropyridine (Entities:
Keywords: 1,4-Dihydropyridines; Cytotoxicity; MTT assay; Nitroimidazole
Year: 2011 PMID: 24250381 PMCID: PMC3813032
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Structure of DHP derivatives used in this study and their calcium channel antagonist activity.
|
|
Cell growth inhibitory activity of compounds a-e in-vitro (IC30).
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| 100 < | 33.1 | 100 < | 58.3 |
| ||
| 100 < | 57.8 | 100 < | 1 > |
| ||
| 100 < | 37.3 | 100 < | 32.5 |
| ||
| 100 < | 58.9 | 100 < | 1 > |
| ||
| 100< | 71.1 | 100 < | 100< |
| ||
| 1 > | 1 > | 1 > | 1 > |
| ||
| 12.6 | 10.5 | 100 < | 12.3 |
| ||
| 5.6 | 1.4 | 1.3 | 1.4 |
| ||
| 5.4 | 1.1 | 1.1 | 1.1 |
| ||
| 3.1 | 1 > | 1 > | 1 |
| ||
| 100 < | 100 < | 100 < | 100 < |
| ||
| 1.7 | 1.2 | 1.2 | 1.4 |
| ||
| 1 > | 1 > | 1 > | 1 > |
| ||
| 1 > | 1 > | 1 > | 1 > |
| ||
| 3.1 | 1.3 | 2.1 | 1.1 |
| ||
| 3.4 | 1> | 1 > | 1 |
| ||
| 100 < | 100 < | 1 > | 100< |
| ||
| 1 > | 1 > | 1 > | 1 > |
| ||
| 100 < | 100 < | 100 < | 100 < |
| ||
a: IC30 is the molar concentration causing 30% growth inhibition of tumor cells
Cell growth inhibitory activity of compounds a-e in-vitro (IC15
|
| |||||
|---|---|---|---|---|---|
| HeLa | Fen | K562 | Raji | Compound | |
| 38.1 | < 1 | 41.8 | < 1 | ||
| 54.7 | < 1 | 84.0 | < 1 |
| |
| 38.8 | < 1 | 6.2 | < 1 |
| |
| 45.5 | < 1 | 20.2 | < 1 |
| |
| 72.4 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | 4.1 | < 1 |
| |
| 1.2 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| 53.5 | 51.5 | 52.5 | > 100 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| 35.5 | 44.7 | 44.4 | 22.4 |
| |
| < 1 | < 1 | < 1 | < 1 |
| |
| 81.1 | 71.4 | 80.4 | 92.4 |
| |
a: IC15 is the molar concentration causing 15% growth inhibition of tumor cells
Cell growth inhibitory activity of compounds a-e in-vitro (IC50).
|
| ||||
|---|---|---|---|---|
|
|
|
|
|
|
| > 100 | > 100 | > 100 | > 100 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| 5.4 | 4.1 | 2.8 | 4.0 |
|
| 68.3 | 56.3 | > 100 | 69.3 |
|
| 30.9 | 15.1 | 14.1 | 15.4 |
|
| 29.4 | 6.8 | 3.0 | 7.1 |
|
| 25.3 | 4.3 | 3.8 | 8.1 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| 14.9 | 14.3 | 14.3 | 14.1 |
|
| < 1 | < 1 | < 1 | < 1 |
|
| 2.8 | 2.4 | 2.5 | 3.1 |
|
| 23.4 | 8.8 | 20.2 | 8.4 |
|
| 28.5 | 7.2 | 3.3 | 8.2 |
|
| > 100 | > 100 | > 100 | > 100 |
|
| < 1 | < 1 | < 1 | < 1 |
|
| > 100 | > 100 | > 100 | > 100 |
|
a: IC50 is the molar concentration causing 50% growth inhibition of tumor cells.